Cancer Therapy News and Research

RSS

Targeting mutant p53 specific binding protein could lead to new therapeutic strategies for cancer patients

Research by Rutgers Cancer Institute of New Jersey investigators shows the targeting of a binding protein of mutant p53 known as Rac1 could lead to new therapeutic strategies for patients whose cancer carries mutations in the p53 gene.

22 Sep 2017

'Labyrinth' chip may be new way to monitor cancer patients in clinical trials

Inspired by the Labyrinth of Greek mythology, a new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial.

21 Sep 2017

Researchers identify exosomes as missing link to insulin resistance in type 2 diabetes

Chronic tissue inflammation resulting from obesity is an underlying cause of insulin resistance and type 2 diabetes. But the mechanism by which this occurs has remained cloaked, until now.

21 Sep 2017

New collaboration could lead to novel drugs that address unmet medical needs

Southern Research and the University of Tennessee Health Science Center have formed a partnership to advance promising research that could lead to new drugs that address unmet medical needs.

20 Sep 2017

Increase in physical activity boosts breast cancer survivors’ mental processing speed

It is estimated that up to 75 percent of breast cancer survivors experience problems with cognitive difficulties following treatments, perhaps lasting years. Currently, few science-based options are available to help.

19 Sep 2017

Salk study shows how fast-growing tumors evade immune system

The immune system automatically destroys dysfunctional cells such as cancer cells, but cancerous tumors often survive nonetheless. A new study by Salk scientists shows one method by which fast-growing tumors evade anti-tumor immunity.

18 Sep 2017

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.

18 Sep 2017

Arkansas professor makes strides toward developing enhanced cancer treatment

A University of Arkansas at Little Rock professor is making strides toward developing an effective cancer treatment without the severe side effects of traditional therapies.

13 Sep 2017

Woman's choice of surgeon plays major role in influencing breast cancer treatment choices

A woman's choice of surgeon plays a significant role in whether she's likely to receive an increasingly popular aggressive breast cancer surgery.

13 Sep 2017

Multigene panel test could be useful to detect patients with hereditary kidney cancer syndrome

A multigene panel test could be a useful diagnostic tool to help clinicians identify patients with a hereditary kidney cancer syndrome, according to the results of a study published in Cancer.

13 Sep 2017

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy, or CIPN, is a common side effect of cancer treatment that causes shooting or burning pain, numbness, tingling and cold sensitivity of the hands and feet for many cancer patients.

13 Sep 2017

Researchers reveal possible origin of cancer-associated fibroblasts

Researchers at Okayama University describe in Scientific Reports that cancer-associated fibroblasts — cells that play a key role in cancer progression — originate from cancer stem cells. Preventing cancer stem cells from transforming into cancer-associated fibroblast may be a promising approach towards cancer treatment.

12 Sep 2017

Study identifies late effects that may interfere with work status of young adult cancer survivors

Factors that limit the work ability of young adult cancer survivors are reported today at the ESMO 2017 Congress in Madrid.

11 Sep 2017

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Rucaparib maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer by 77%, according to late-breaking results from the ARIEL3 trial reported today at the ESMO 2017 Congress in Madrid.

8 Sep 2017

Comprehensive analysis reveals cumulative burden of chronic disease in childhood cancer survivors

The most complete assessment yet of chronic disease in adult survivors of childhood cancer found they have a nearly two-fold greater cumulative burden of chronic health problems than the general public.

8 Sep 2017

Researchers define how cancer drug works in cells, mice and man

Science is very good at determining how drugs work in experimental models. New research out of Dartmouth's Norris Cotton Cancer Center led by Alan Eastman, PhD, helps to bridge the gap when it comes to ensuring that drugs work by the same mechanism in human patients.

7 Sep 2017

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

European women with ovarian cancer can safely stick to the standard three-week dosing schedule for paclitaxel rather than boosting up to a weekly dose-dense regimen, according to results of the phase III ICON8 trial to be presented at the ESMO 2017 Congress in Madrid.

4 Sep 2017

Existing drug may one day protect premenopausal women from infertility after cancer treatments

An existing drug may one day protect premenopausal women from life-altering infertility that commonly follows cancer treatments, according to a new study.

1 Sep 2017

Why one California County went surgery shopping

Retiree Leslie Robinson-Stone and her husband enjoyed a weeklong, all-expenses-paid trip to a luxury resort — all thanks to the county she worked for.

1 Sep 2017

Motorized molecules driven by light to cut into cancer cells

Researchers have developed a novel technique where molecules would be motorized using light and these would be used to drill holes in the membranes of individual cells such as the cancer cells. This could bring the treatment molecule into the cancer cell directly and cause them to die.

31 Aug 2017

Cancer Therapy News and Research

Targeting mutant p53 specific binding protein could lead to new therapeutic strategies for cancer patients

'Labyrinth' chip may be new way to monitor cancer patients in clinical trials

Researchers identify exosomes as missing link to insulin resistance in type 2 diabetes

New collaboration could lead to novel drugs that address unmet medical needs

Increase in physical activity boosts breast cancer survivors’ mental processing speed

Salk study shows how fast-growing tumors evade immune system

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Arkansas professor makes strides toward developing enhanced cancer treatment

Woman's choice of surgeon plays major role in influencing breast cancer treatment choices

Multigene panel test could be useful to detect patients with hereditary kidney cancer syndrome

Study finds potential preventive for chemotherapy-induced peripheral neuropathy

Researchers reveal possible origin of cancer-associated fibroblasts

Study identifies late effects that may interfere with work status of young adult cancer survivors

Study: Maintenance therapy increases progression-free survival in BRCA mutant recurrent ovarian cancer

Comprehensive analysis reveals cumulative burden of chronic disease in childhood cancer survivors

Researchers define how cancer drug works in cells, mice and man

Trial confirms standard three-week dosing of chemotherapy as first line treatment in ovarian cancer

Existing drug may one day protect premenopausal women from infertility after cancer treatments

Why one California County went surgery shopping

Motorized molecules driven by light to cut into cancer cells

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News